Bio Preventive Medicine Corp. (6810.TWO)
TWD 30.55
(0.16%)
TWD 30.55
(0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -63.89 Million | -54.62 Million | -44.82 Million | -46.22 Million | - |
| Net Income | -73.28 Million | -70.94 Million | -67.22 Million | -64.83 Million | - |
| Depreciation & Amortization | 8.24 Million | 16.25 Million | 21.36 Million | 21.22 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 674 Thousand | - | - | - | 12.76 Million |
| Change in working capital | 993 Thousand | 52 Thousand | 1.01 Million | -2.64 Million | - |
| Other non-cash items | 1.94 Million | 516 Thousand | -153 Thousand | 38 Thousand | - |
| Investing Cash Flow | -933 Thousand | -81.02 Million | -50.64 Million | -22.79 Million | - |
| Investments in PPE | -1.76 Million | -152.65 Million | -3.14 Million | -277 Thousand | - |
| Acquisitions | 500 Thousand | - | - | - | - |
| Investment purchases | - | - | -150 Million | -50 Million | - |
| Sales/Maturities of investments | - | 70 Million | 102.5 Million | 27.5 Million | - |
| Other Investing Activities | 330 Thousand | 1.63 Million | - | -16 Thousand | -315 Thousand |
| Financing Cash Flow | 64.53 Million | 189.15 Million | -3.36 Million | 76.26 Million | - |
| Debt repayment | -7.2 Million | -120.6 Million | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 72 Million | 73.45 Million | - | 83.12 Million | - |
| Other Financing Activities | -263 Thousand | 151 Thousand | 3.39 Million | - | 70.05 Million |
| Accounts receivables | 114 Thousand | - | - | - | - |
| Accounts payables | -140 Thousand | - | - | - | - |
| Inventory | 50 Thousand | -281 Thousand | 191 Thousand | -1.19 Million | - |
| Other working capital | 829 Thousand | - | - | - | - |
| Cash at beginning of period | 81.92 Million | 28.42 Million | 127.26 Million | 120.01 Million | - |
| Cash at end of period | 81.63 Million | 81.92 Million | 28.42 Million | 127.26 Million | - |
| Capital Expenditure | -1.76 Million | -152.65 Million | -3.14 Million | -277 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -289 Thousand | 53.5 Million | -98.84 Million | 7.25 Million | - |
| Free Cash Flow | -65.65 Million | -207.28 Million | -47.97 Million | -46.5 Million | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -42.03 Million | -73.28 Million | -38.05 Million | -35.22 Million | -34.12 Million | -70.94 Million |
| Depreciation & Amortization | 3.99 Million | 8.24 Million | 4.03 Million | 4.2 Million | 5.9 Million | 16.25 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 674 Thousand | - | - | - | - |
| Change in working capital | -2.17 Million | 993 Thousand | 3.22 Million | -1.24 Million | 3.79 Million | 52 Thousand |
| Other non-cash items | -1000.00 | 1.94 Million | -5000.00 | 163 Thousand | -4000.00 | 516 Thousand |
| Investing Cash Flow | -91 Thousand | -933 Thousand | 110 Thousand | -1.04 Million | -99.75 Million | -81.02 Million |
| Investments in PPE | -91 Thousand | -1.76 Million | -220 Thousand | -1.54 Million | -105.76 Million | -152.65 Million |
| Acquisitions | - | - | - | 500 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 5 Million | 70 Million |
| Other Investing Activities | - | 330 Thousand | 330 Thousand | - | 1.63 Million | 1.63 Million |
| Financing Cash Flow | 57.54 Million | 64.53 Million | -3.96 Million | 67.5 Million | 120.15 Million | 189.15 Million |
| Debt repayment | -3.41 Million | -7.2 Million | -3.96 Million | -4.23 Million | -121.28 Million | -120.6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 72 Million | - | 72 Million | 89 Thousand | 73.45 Million |
| Other Financing Activities | 60.96 Million | - | - | -263 Thousand | -1.22 Million | 151 Thousand |
| Accounts receivables | -602 Thousand | - | -123 Thousand | 237 Thousand | 234 Thousand | - |
| Accounts payables | 138 Thousand | - | 40 Thousand | -180 Thousand | 164 Thousand | - |
| Inventory | -280 Thousand | 50 Thousand | -21 Thousand | 71 Thousand | -39 Thousand | -281 Thousand |
| Other working capital | -1.43 Million | - | 3.33 Million | -1.37 Million | 3.43 Million | - |
| Cash at beginning of period | 81.63 Million | 81.92 Million | 116.28 Million | 81.92 Million | 85.95 Million | 28.42 Million |
| Cash at end of period | 98.87 Million | 81.63 Million | 81.63 Million | 116.28 Million | 81.92 Million | 81.92 Million |
| Capital Expenditure | -91 Thousand | -1.76 Million | -220 Thousand | -1.54 Million | -105.76 Million | -152.65 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 17.23 Million | -289 Thousand | -34.64 Million | 34.35 Million | -4.03 Million | 53.5 Million |
| Free Cash Flow | -40.3 Million | -65.65 Million | -31.01 Million | -33.64 Million | -130.19 Million | -207.28 Million |
LLOYDSME
5831
FUJIF
MRGN
MHTX
1776